Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Quiet here, I see DEMG are upgrading their Cardio Q in order that the oxygen delivery rate can be monitored.
2517

Got out of this earlier this week...got fed up with it as it promises alot but... no real sales etc.,,, I topped up on BLR with the proceeds..! this'll gush....!

With all the positive feed from the trials, and now an upgrade, this will eventually take off big style. I wonder if the US market have influenced this. Can only be good for the product.

See where you're coming from, but with respect... we've heard it all before it's pure hype imho

Can't see how this can be hype. All the trials have been accepted as proven success. Deltex have never ( unless you can find to the contrary ) hyped this product, or the sp, they have let the trial results, and the medical professions comments do all the talking. They have always maintained that the NHS is a very big hurdle to overcome due to it's bureaucracy. And as to adding the additional, to the CardioQ how can that be hype. Like you I got out of this share about 9 months ago due to running out of patience, but bought back almost immediately. Hope I made the right choice, and that you did not lose out too much, if at all. ( Nice to see more activity on this thread, whether contrary to my views or not ).
Cheers Greek.

The Count,

I, too, post over on the dark side and I am finding this discussion about the identity of the mystery Christou very interesting. Your speculations as to his identity are hilarious. Please do carry on.

I notice he has the initials J.C. Is he perhaps modelling himself on Julius Ceasar, or on someone even more famous? I think we should be told.

skyhigh,
Deltex sold about 36 monitors to the NHS in the whole of 2005. They sold 24 monitors to the NHS in the first four months of this year. (source: RNS items, AGM statements, AFX news and stuff) Being pessimistic, it won't take long until they exceed last year's monitor sales. Being optimistic, 24 monitors in 4 months suggests 72 monitors in 12 months. That's double last year's sales. That's a reason to buy.

monitor - isn't that a lizard? Perhaps they meant minotaur instead. They could mean mini-tor, which is a small hill in Devon. Remind me again what this company does. I have to say I'm surprised that the NHS is buying lizards. Maybe it makes the reptilian management feel more at home.

Arf Dysg,

As you say, good increase in sales, also with the upgrade of the CardioQ, no doubt those that are already in use will also be requiring the adaption at the request of the users. I would think that to modify existing Cardio's would be a fairly easy task. This is after talking to a couple of medical people, who although have no connection with the device regularly use medical equipment such as monitors.
Would be nice to see a bit more detail on the upgrade and how easily adaptable it is to modify.

Arf - I to have the initials JC but wouldn't buy this stock at present. So Deltex has upgraded its CardioQ, well I suppose it needs some excuse to justify yet another years loss to its shareholders and what better then R&D.

Explosive,

So I suppose the only reason to spend money on R&d re the upgrade is to spend it for the sole reason of conning the investor. The year loss was expected, so they don't need an excuse. Deltex as most long term holders know are a couple of years from decent profits, even if all goes well.

I suspect that upgrading existing monitors to the new capability (oxygen delivery) is very easy. The hardware won't change - it's very likely to be an upgrade to the software in the monitor. The software would be responsible for interpreting the signals coming from the ultrasound probe. Since the capability now exists, it ought to be easy to send the software update (if requested) to existing users.

Hi Arf,

Don't know much about IT stuff as a bit of a technophobe, but like you I doubt if the upgrades will take much doing.

Nice RNS, shows things are progressing nicely.

This is the best bit.... Their launch is primarily aimed at the high volume,
operating theatre market.

If it becomes acceptable routine practice in the USA, there should be no looking back.

Finance News
Latest UK-related finance news headlines
Tuesday, 11th July 2006 17:07

Still in the health sector, Deltex Medical Group was buoyed by news it has launched an extended range of probes for use with its CardioQ monitor in the US.

Not much of a mention. We still need that big break through contract wise to wake up the institutions and the media interest.

From The Stock Market Report, by Uk Analyst,
A snippet only due to copyright.

Deltex Medical
The timing of this launch coincides with signs of increasing demand from anaesthetists and surgeons to implement Targeted Volume Management using the CardioQ in operating theatres.

Nice and steady as she goes.
From the RNS trading statement...... June was
the twentieth consecutive month when UK probe sales were higher than in the
corresponding month the year before. March was a record month for probe sales
and June the second highest ever.
They also appear to be cash okay up to profitability.
I expect in 12 months time a similar release stating once again "June was
the twentieth consecutive month when UK probe sales were higher" will be stated.
Also expect in that time scale US sales to be progressing nicely.
I am not one to guesstimate SP in the future, but I do expect next years corresponding price to be a good bit higher than it is now.
Looking very good (and yet the sp as I post is down .25p) strange.

I was under the impression that the Cardio Q machine costs in the region of 50k, if that is the case then we are talking about an additional 2 machines sold this half compared to the same period last year, with not much in there for the probes.
2517

From the most recent report I could find.

The initial cost to the NHS to purchase a haemodynamic monitor (cardioQ) is 7,000, and an additional cost of 60 to use CardioQ in a patient's care, it is clear that when the device is saving approximately 800 per patient, the technology pays for itself.

End of extract.

So although obvious to the NHS, they are still reluctant to spend 1 today to save 2 tomorrow. It appears most NHS managers have had surgery, Lobotomy springs to mind.
So unless the cost since then has risen dramatically, 50k each is way off the mark.
I would be interested to know where the figure of 50k comes from.
My figures come from a House of Commons report, dated July 2006.

Just as an interest, the following extract is from the same report.

In 2005 in her speech to the NHS Confederation conference, Health Secretary, Rt Hon Patricia Hewitt MP underlined the need to invest in ways to reduce hospital stays when she said, "If a shorter stay in hospital gives the patient as good, or better outcomes, and it costs less, lets do it." There is a clear financial and clinical argument for introducing new technology which has the ability to reduce patient stays in hospital. At a time when the NHS is searching for greater efficiencies to reduce deficits, it seems inconceivable that uptake of a product which has been proven to do exactly that, is proving incredibly difficult to achieve.

P Hewitt was referring in this particular instance to the CardioQ.
Nice, fancy-full words from an MP but that's obviously all they were, words.

greekman---------thanks for that, I was certain that I'd read the cost was 50k and whilst I wouldn't believe anything emanating from the House of Commons, I bow to your superior knowledge of DEMG, apologies for misleading. I hold these, having paid slightly more than their current sp, so I want them to rise. Meanwhile I'll check my notes for the error.
2517

2517,

No problem. It took me ages to find anything relating to the CardioQ cost per unit.
Re your comment House of Commons, you are obviously doubting our respected members of parliament. I chose this report as obviously every word is true. Surely you don't mean to give the impression that they tell less than the truth. You will be saying next that you don't believe our most eminent leader, and his merry men. Don't forget that we are not like those corrupt countries we read about. We are a democracy. I fully trust the government with my pension, health, education and future. OK I have no choice, otherwise the whole pathetic lot would be out.
Sorry to go off thread. Had my ramble now, but it is a fact that we have a fantastic, no brainer piece of kit, that the powers that be are paid vast overrated salaries to deny it's use.
As to the unit cost, if anyone can confirm pricing I would appreciate it.
As 2517 states House of Commons reports do have a habit of getting facts and figures wrong.